Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

IMPORTANCE: Fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) and gemcitabine plus nanoparticle albumin-bound (nab)–paclitaxel (GA) are first-line chemotherapy regimens for pancreatic cancer. Their relative efficacy in the setting of localized disease is unknown. OBJECTIVE: To evalu...

詳細記述

保存先:
書誌詳細
出版年:JAMA Surg
主要な著者: Perri, Giampaolo, Prakash, Laura, Qiao, Wei, Varadhachary, Gauri R., Wolff, Robert, Fogelman, David, Overman, Michael, Pant, Shubham, Javle, Milind, Koay, Eugene J., Herman, Joseph, Kim, Michael, Ikoma, Naruhiko, Tzeng, Ching-Wei, Lee, Jeffrey E., Katz, Matthew H. G.
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2020
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364337/
https://ncbi.nlm.nih.gov/pubmed/32667641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2020.2286
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料